Position in LQDA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,918,862
+$3,631,060 QoQ
Shares Held
61,694
+80.8% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 334 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $154,257,402 across 47 Drug Manufacturers - Specialty & Generic names. LQDA ranks #11 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
368,249 | $26,462,373 | |
| 2 | HLN |
Haleon plc
|
2,036,156 | $18,997,335 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,431,267 | $14,870,864 | |
| 4 | VTRS |
Viatris Inc
|
678,057 | $10,767,545 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
432,525 | $10,644,440 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
62,420 | $10,520,266 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
258,667 | $8,967,984 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
555,228 | $8,900,304 |
All Filings in LQDA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,918,862 | 61,694 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,287,802 | 34,123 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,144,723 | 33,190 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $638,994 | 28,100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $173,754 | 13,945 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $212,695 | 14,420 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $144,883 | 12,320 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $119,200 | 11,920 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $418,200 | 34,850 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||